aspartic acid has been researched along with Carcinoma, Epidermoid in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peters, GJ | 1 |
| Hao, H; Hong, T; Kai, Y; Yunlong, B | 1 |
| Chen, WT; Qu, XZ; Ruan, M; Yan, M; Yang, WJ; Zhang, CP; Zhou, XJ | 1 |
| Liang, G; Lin, DX; Lu, WF; Miao, XP; Qi, J; Tan, W; Wu, M; Xing, DY; Yu, CY; Zhou, CN | 1 |
| BENNETT, LL; SMITHERS, D; WARD, CT | 1 |
| Annable, T; Greenberger, LM; Hari, M; Loganzo, F; Morilla, DB; Musto, S; Nettles, JH; Snyder, JP; Tan, X | 1 |
| Cortes-Funes, H; Gamarra, S; Hitt, R; Manso, L; Medina, PP; Quintela-Fandino, M; Sanchez-Cespedes, M | 1 |
| Briggle, TV; Greer, S; Mekras, JA; Perez, LM | 1 |
| Iwasaki, K; Izawa, M; Mihara, M | 1 |
| Aks, C; Clark, J; DeMaria, D; Johnson, C; Langer, CJ; Leighton, J; Litwin, S; Reilly, DM; Ridge, JA; Sauter, E; Schaebler, D | 1 |
| Hayashi, T; Kobayashi, M; Kuroki, M; Sakata, I; Tajiri, H | 1 |
| Agarwal, S; Mathur, M; Ralhan, R; Srivastava, A; Wasylyk, B | 1 |
| Alcalde, RE; Matsumura, T; Mese, H; Nakayama, S; Sasaki, A | 1 |
| Giga-Hama, Y; Goto, H; Isoai, A; Kumagai, H; Ueno, Y | 1 |
| Davidson, K; Forseth, B; Scott, J; Von Hoff, DD; Waddelow, T; Wahl, G | 1 |
| Colofiore, J; Derby, S; Kemeny, N; Martin, DS; Salvia, B; Sawyer, RC; Schneider, A | 1 |
| Fasce, CF; Rej, R; Vanderlinde, RE | 1 |
1 trial(s) available for aspartic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Fluorouracil; Genes, p53; Head and Neck Neoplasms; Humans; Interferon-alpha; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Phosphonoacetic Acid; Survival Analysis; Treatment Failure | 1998 |
16 other study(ies) available for aspartic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
Topics: Amides; Antineoplastic Agents; Aspartate Carbamoyltransferase; Aspartic Acid; Biphenyl Compounds; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Carcinoma, Squamous Cell; Cell Line, Tumor; Dihydroorotate Dehydrogenase; Head and Neck Neoplasms; Humans; Isoxazoles; Naphthoquinones; Orotate Phosphoribosyltransferase; Oxidoreductases Acting on CH-CH Group Donors; Phosphonoacetic Acid; Purine Nucleotides; Pyrazoles; Pyrimidine Nucleotides; Ribonucleosides; Ribose | 2018 |
[In situ visual imaging of oral squamous cell carcinoma in mice by using near-infrared quantum dots conjugated with arginine-glycine-aspartic acid peptide fluorescent probes].
Topics: Animals; Arginine; Aspartic Acid; Carcinoma, Squamous Cell; Cell Line, Tumor; Fluorescent Dyes; Glycine; Humans; Mice; Mice, Nude; Mouth Neoplasms; Oligopeptides; Peptides; Quantum Dots | 2014 |
[Role of NF-kappaB pathway in shikonin induced apoptosis in oral squamous cell carcinoma Tca-8113 cells].
Topics: Apoptosis; Aspartic Acid; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Mouth Neoplasms; Naphthoquinones; NF-kappa B; Signal Transduction | 2010 |
[Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
Topics: Adenocarcinoma; Asparagine; Aspartic Acid; Carcinoma, Squamous Cell; China; DNA; DNA Helicases; DNA Repair; DNA-Binding Proteins; Esophageal Neoplasms; Female; Gene Frequency; Genotype; Humans; Logistic Models; Lung Neoplasms; Male; Multivariate Analysis; Odds Ratio; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proteins; Risk Factors; Smoking; Transcription Factors; Xeroderma Pigmentosum Group D Protein | 2003 |
INHIBITION OF DNA SYNTHESIS IN MAMMALIAN CELLS BY ACTIDIONE.
Topics: Adenine; Adenine Nucleotides; Anti-Bacterial Agents; Aspartic Acid; Carbon Isotopes; Carcinoma, Squamous Cell; Cycloheximide; Cytosine Nucleotides; DNA; DNA Replication; DNA, Neoplasm; Formates; Glycine; Guanine Nucleotides; Leucine; Metabolism; Neoplasms; Nucleosides; Nucleotides; Nucleotidyltransferases; Orotic Acid; Pharmacology; Research; RNA; RNA, Neoplasm; Thymidine; Tissue Culture Techniques; Tritium | 1964 |
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents, Phytogenic; Aspartic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Epothilones; Glutamic Acid; Humans; Mice; Mice, Nude; Microtubules; Paclitaxel; Point Mutation; Protein Conformation; Taxoids; Tubulin; Verapamil | 2006 |
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Asparagine; Aspartic Acid; Carcinoma, Squamous Cell; Cisplatin; Cysteine; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Female; Gene Frequency; Genotype; Glutamine; Head and Neck Neoplasms; Humans; Lysine; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein | 2006 |
Marked radiosensitization of cells in culture to X ray by 5-chlorodeoxycytidine coadministered with tetrahydrouridine, and inhibitors of pyrimidine biosynthesis.
Topics: Animals; Aspartic Acid; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Deoxycytidine; Dose-Response Relationship, Radiation; Floxuridine; Humans; Laryngeal Neoplasms; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Tetrahydrouridine; Uridine | 1984 |
Involvement of caspases in apoptosis induced by ultraviolet B irradiation in A431 human epithelioid tumor cells.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Aspartic Acid; Carcinoma, Squamous Cell; Caspase 1; Caspase 3; Caspases; Cell Survival; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Humans; Oligopeptides; Tumor Cells, Cultured; Ultraviolet Rays | 1997 |
Tumor-enhancement effect of a Mn3+ metalloporphyrin derivative (ATN-4T) in magnetic resonance imaging.
Topics: Animals; Aspartic Acid; Carcinoma, Squamous Cell; Contrast Media; Deuteroporphyrins; Image Enhancement; Magnetic Resonance Imaging; Neoplasm Transplantation; Neoplasms; Rabbits | 1999 |
Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Topics: Adult; Aged; Alleles; Antibodies, Monoclonal; Apoptosis; Aspartic Acid; Carcinoma, Squamous Cell; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Exons; Female; Genes, p53; Glycine; Humans; Immunohistochemistry; Leukoplakia; Lymphocytes; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Mutation, Missense; Polymorphism, Genetic; Precancerous Conditions | 2000 |
The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line.
Topics: Antineoplastic Agents; Apoptosis; Aspartic Acid; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Caspase Inhibitors; Caspases; Cisplatin; DNA Fragmentation; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Humans; Inhibitory Concentration 50; Protease Inhibitors; Tumor Cells, Cultured | 2000 |
A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptide-mediated inhibition of tumor metastasis.
Topics: Animals; Anticarcinogenic Agents; Arginine; Aspartic Acid; Carcinoma, Squamous Cell; Cell Adhesion; Collagen; Female; Fibronectins; Glycine; Glycoproteins; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasm Metastasis; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Protein Binding; Vitronectin | 1992 |
Hydroxyurea accelerates loss of extrachromosomally amplified genes from tumor cells.
Topics: Aspartate Carbamoyltransferase; Aspartic Acid; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Carcinoma, Squamous Cell; Cell Division; Chromosome Deletion; Dihydroorotase; DNA Replication; Drug Resistance; Gene Amplification; Humans; Hydroxyurea; Methotrexate; Multienzyme Complexes; Phosphonoacetic Acid; Plasmids; Tumor Cells, Cultured; Vinblastine | 1991 |
Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Bone Marrow; Carcinoma, Squamous Cell; Colorectal Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Pentosephosphates; Phosphonoacetic Acid; Phosphoribosyl Pyrophosphate | 1989 |
Increased aspartate aminotransferase activity of serum after in vitro supplementation with pyridoxal phosphate.
Topics: Adult; Aspartate Aminotransferases; Aspartic Acid; Carcinoma, Squamous Cell; Colorimetry; Cytoplasm; Dose-Response Relationship, Drug; Drug Stability; Erythrocytes; Evaluation Studies as Topic; Female; Glutamate Dehydrogenase; Humans; Kinetics; Liver Neoplasms; Male; Methods; Middle Aged; Pyridoxal Phosphate; Regression Analysis; Renal Dialysis; Spectrophotometry, Ultraviolet; Time Factors | 1973 |